Sanofi and GSK recently announced they will delay a program testing an adjuvanted COVID-19 vaccine after results from a Phase 1/2 study showed a low immune response in older adults.
The...
Tremeau Pharmaceuticals recently announced that Gurnet Point Capital will fund its non-opioid program to clinically develop its investigational drug, TRM-201.
Additionally, the funding will also...
Moderna recently announced that the Canadian Government will now acquire an additional 20 million doses of its mRNA COVID-19 vaccine, bringing the total to 40 million doses.
The updated...
Cerner recently announced that an investment in Elligo Health Research will increase access to clinical trials by offering clinical trial resourcesin the Cerner Learning Health...
AbbVie and Frontier Medicines recently announced a multi-year global strategic collaboration to discover, develop, and commercialize a pipeline of innovative novel drug therapies against...
Eli Lilly & Company and Precision BioSciences recently announced a collaboration to research and develop potential in vivo gene therapies for genetic disorders.
The collaboration and exclusive...
Although prepublication news releases for COVID-19 antibody drugs are common, they often leave clinicians uncertain about how to best leverage the treatments, which are usually in short supply,...
Medication management is crucial to improving health outcomes, especially in long-term care facilities and inpatient care settings. But packaging prescriptions for the vulnerable population can be a...
FDA recently published a list of 223 essential medicines, medical countermeasures, critical inputs to have available at all times and serve patient needs in the appropriate dosage forms.
The product...
HHS and the Department of Defense (DoD) recently announced an agreement with Eli Lilly and Company to purchase the first doses of the company’s COVID-19 antibody therapeutic, LY-CoV555.
The...
A Pioneer Institute report found that market reforms using “push” and “pull” funding will help to combat the global antimicrobial resistance crisis.
The CDC considers...
Eli Lilly and Company and the Bill & Melinda Gates Foundation recently entered into an agreement to facilitate access to future COVID-19 antibody therapies in low-and middle-income...
A recent Health Affairs study found that 64 percent of new biologic and drug indications deemed relevant to pediatric patients lacked pediatric prescribing information five years after FDA...
Johnson & Johnson recently announced the completion of a $6.5 billion pharmaceutical acquisition deal involving biotechnology company Momenta Pharmaceuticals, Inc.
This announcement comes a...
Sanofi and GSK recently finalized an agreement with the European Commission (EC) for the supply of up to 300 million doses of their COVID-19 vaccine, once the vaccine is approved.
The agreement will...
A recent study found that switching from brand name to generic cholesterol medications has saved Medicare billions of dollars between 2014 and 2018, even as the number people on cholesterol-lowering...
After substantial review, NIH’s COVID-19 Treatment Guidelines Panel found that there were insufficient data to recommend either for or against the use of convalescent plasma for the treatment of...
HHS recently issued a third amendment to the Declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to expand access to lifesaving childhood vaccines during the COVID-19...
The Corona Accelerated R&D in Europe (CARE) recently launched to quicken COVID-19 therapy development leveraging both public and private companies.
For more coronavirus updates, visit...
Bristol Myers Squibb recently announced it acquired Dragonfly Therapeutics’ investigational immunotherapy program for $475 million.
Under the definitive agreement, Bristol Myers Squibb will be...
